Cita APA

Kitadate, A., Ikeda, S., Abe, F., Takahashi, N., Shimizu, N., Matsue, K., & Tagawa, H. (2018). Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas. Haematologica.

Chicago Style Citation

Kitadate, Akihiro, Sho Ikeda, Fumito Abe, Naoto Takahashi, Norio Shimizu, Kosei Matsue, i Hiroyuki Tagawa. "Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-positive Mature T-cell Lymphomas." Haematologica 2018.

Cita MLA

Kitadate, Akihiro, et al. "Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-positive Mature T-cell Lymphomas." Haematologica 2018.